July 22, 2022 Comments Off on New patent for Abbvie Inc drug VENCLEXTA Posted in: Patent Added Annual Drug Patent Expirations for VENCLEXTA Venclexta is a drug marketed by Abbvie Inc and is included in one NDA. It is available from one supplier. There are seven patents…
The post New patent for Abbvie Inc drug VENCLEXTA appeared first on DrugPate…
July 22, 2022 Comments Off on New patent expiration for Boehringer Ingelheim drug SPIRIVA Posted in: Uncategorized
Annual Drug Patent Expirations for SPIRIVA Spiriva is a drug marketed by Boehringer Ingelheim and is included in two NDAs. It is available from two suppliers. There are sixteen patents…
The post New patent expiration for Boehringer Ingelheim drug SPIRI…
